Lumbar spinal fusion using recombinant human bone morphogenetic protein in the canine: A comparison of three dosages and two carriers

Spine

Volumn 24, Issue 19, 1999, Pages 1973-1979

  David, Stephen M ^a   Gruber, Helen E ^a   Meyer Jr , Ralph A ^a   Murakami, Takanori ^a   Tabor, Owen B ^a   Howard, Brian A ^a   Wozney, John M ^b   Hanley Jr , Edward N ^a  

^a CAROLINAS MEDICAL CENTER   (United States)

^b PFIZER INC   (United States)

Author keywords

Bone grafting; Lumbar spinal fusion; RhBMP 2

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; COLLAGEN TYPE 1; POLYLACTIC ACID; RECOMBINANT PROTEIN;

ADOLESCENT; ANIMAL TISSUE; ARTICLE; BIOCOMPATIBILITY; BIODEGRADATION; BONE GRAFT; CONTROLLED STUDY; DOG; LUMBAR SPINE; MORPHOMETRICS; NONHUMAN; PRIORITY JOURNAL; SPINE FUSION;

EID: 0033215480     PISSN: 03622436     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007632-199910010-00002     Document Type: Article

References (29)

1. Bauer FCH, Urist MR. Human osteosarcoma-derived soluble bone morphogenetic protein. Clin Orthop 1981;154:291-5.
2. Bentz H, Nathan RM, Rosen DM, et al. Purification and characterization of a unique osteoinductive factor from bovine bone. J Biol Chem 1989;264:20805-10.
3. Callewart CC, Kanim LEA, Seeger LL, Dawson EG. Variable fusion rates in the canine model. Presented at the 29th Annual Meeting of the Scoliosis Research Society, Portland, Oregon, September 21-24, 1994.
4. Celeste AJ, Iannazzi JA, Taylor RC, et al. Identification of transforming growth factor beta family members present in bone-inductive protein purified from bovine bone. Proc Natl Acad Sci USA 1990;87:9843-7.
5. Cook SD, Dalton JE, Tan EH, Whitecloud TS III, Rueger DC. In vivo evaluation of recombinant human osteogenic protein (rhOP-1) implants as a bone graft substitute for spinal fusions. Spine 1994;19:1655-63.
6. Cotler JM, Star AM. Complications of spinal fusions. In: Cotler JM, Cotler HB, eds. Spinal Fusion: Science and Technique. New York: Springer-Verlag, 1990:361-87.
7. Holliger EH, Trawick RH, Boden SD, Hutton WC. Morphology of the lumbar intertransverse process fusion mass in the rabbit model: A comparison between two bone graft materials - rhBMP-2 and autograft. J Spinal Disord 1996; 9:125-8.
8. Kanatani M, Sugimoto T, Kaji H, et al. Stimulatory effect of bone morphogenetic protein-2 on osteoclast-like cell formation and bone-resorbing activity. J Bone Miner Res 1995;10:1681-90.
9. Kurz LT, Garfin SR, Booth RE Jr. Harvesting autogenous iliac bone grafts: A review of complications and techniques. Spine 1989;14:1324-31.
10. Lichtblau S. Dislocation of the sacroiliac joint. J Bone Joint Surg [Am] 1962; 44:193-8.
11. Lovell TP, Dawson EG, Nilsson OS, Urist MR. Augmentation of spinal fusion with bone morphogenetic protein in dogs. Clin Orthop 1989;243:266-74.
12. Reddi AH. Cell biology and biochemistry of endochondral bone development. Collagen and Related Research (Stuttgart) 1981;1:209-26.
13. Reddi AH, Huggins C. Biochemical sequences in the transformation of normal fibroblasts in adolescent rats. Proc Natl Acad Sci USA 1972;69:1601-5.
14. Sampath TK, Coughlin JE, Whetstone RM, et al. Bovine osteogenic protein is composed of dimers of OP-1 and BMP-2A, two members of the transforming growth factor-beta superfamily. J Biol Chem 1990;265:13198-205.
15. Sandhu HS, Kanim LEA, Kabo JM, et al. Effective doses of recombinant human bone morphogenetic protein-2 in experimental spinal fusion. Spine 1996; 21:2115-22.
16. Sandhu HS, Kanim LEA, Kabo JM, et al. Evaluation of rhBMP-2 with an OPLA carrier in a canine posterolateral (transverse process) spinal fusion model. Spine 1995;20:2669-82.
17. Schimandle JH, Boden SD, Hutton WC. Experimental spinal fusion with recombinant human bone morphogenetic protein-2. Spine 1995;20:1326-37.
18. Summers BN, Eisenstein SM. Donor site pain from the ilium: A complication of lumbar spine fusion. J Bone Joint Surg [Br] 1989;71:677-80.
19. Ubhi CS, Morris DL. Fracture and herniation of bowel at bone graft donor site in the iliac crest. Injury 1984;16:202-3.
20. Urist MR. Bone: Formation byautoinduction. Science 1965;150:893-9.
21. Urist MR, Dawson E. Intertransverse process fusion with the aid of chemosterilized autolyzed antigen-extracted allogeneic (AAA) hone. Clin Orthop 1981; 154:97-113.
22. Urist MR, DeLange RJ, Finerman GAM. Bone cell differentiation and growth factors. Science 1983;220:680-6.
23. Urist MR, Iwata H, Ceccotti PL, et al. Bone morphogenesis in implants of insoluble bone gelatin. Proc Natl Acad Sci USA 1973;70:3511-15.
24. Urist MR, Mikulski A, Lietze A. Solubilized and insolubilized bone morphogenetic protein. Proc Natl Acad Sci USA 1979;76:1828-1832.
25. Wang EA, Rosen V, Cordes P, et al. Purification and characterization of other distinct bone-inducing factors. Proc Natl Acad Sci USA 1988;85:9484-8.
26. Wang EA, Rosen V, D'Alessandro JS, et al. Recombinant human bone morphogenetic protein induces bone formation. Proc Natl Acad Sci USA 1990;87: 2220-4.
27. Wozney JM, Rosen V, Celeste AJ, et al. Novel regulators of bone formation: Molecular clones and activities. Science 1988;242:1528-34.
28. Yasko AW, Lane JM, Fellinger EJ, Rosen V, Wozney JM, Wang EA. The healing of segmental bone defects induced by recombinant human bone morphogenetic protein (rhBMP-2): A radiographic, histological, and biomechanical study in rats. J Bone Joint Surg [Am] 1992;74A:659-70.
29. Younger EM, Chapman MW. Morbidity at bone graft donor sites. J Orthop Trauma 1989;3:192-5.